Lv1
70 积分 2022-07-13 加入
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
8天前
已完结
The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study
22天前
已完结
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
22天前
已完结
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
1个月前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
1个月前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
1个月前
已完结
[Chinese expert consensus on the combination of immune checkpoint inhibitors and radiotherapy for lung cancer (2025 edition)]
2个月前
已完结
Bronchoscopic Treatment of Tracheobronchial Neoplasms
3个月前
已关闭
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
4个月前
已完结
皖公网安备34019202002308
